Clinical Trials
7 trialsNCT05816694 2023-04-18
The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT00003606 2021-02-21
Combination Chemotherapy in Treating Patients With Extensive Stage Small Cell Lung Cancer
UNICANCER
Phase 3 Completed
NCT03755115 2019-01-16
SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT00017186 2016-12-07
Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00658580 2015-02-12
Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer
European Lung Cancer Working Party
Phase 3 Completed
NCT00011921 2013-09-17
Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00154739 2008-08-04
Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)
National Taiwan University Hospital
Phase 2 Completed